How does someone access these reports? From a broker? Direct from the analyst? From a consolidator? Are these research reports regulated? Are they released to everyone at the same time? If a random report can move the stock 20% and certain people have a access to it before others, I can see a lot of abuse potential there. However, that must be the raison d'être of these reports. I still could not figure out the mechanism of publishing and accessing these reports.
Also I wonder what ratio of people trading a stock after a report are investors investing because of the information in the report vs traders because of the sentiment in the report.
The only piece of hard info I don't remember seeing before is that SNTA mgt believes the value of Ganetespib is likely to be more driven by the Galaxy subgroups than the ALK+ mono therapy. Not that this is a surprise given previous disclosures by the company and a little thought. But given that it probably comes from subsequent conversations with mgt it implies that they aren't reconsidering their previous disclosures.
News 
Market Data 
Discover 
